GOCO Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

88.62M

-77.23%

-2.093

-234.16%

62.80M

-71.58%

-1.806

+247.31%

34.61M

-63.2%

-1.986

-61.06%

Estimates Revision

The market is revising Downward the revenue expectations for GoHealth, Inc. (GOCO) for FY2025, with the revenue forecasts being adjusted by -45.08% over the past three months. During the same period, the stock price has changed by -49.25%.

Revenue Estimates for FY2025

Revise Downward

-45.08%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-1.56%

In Past 3 Month

Stock Price

Go Down

-49.25%

In Past 3 Month

3 Analyst Rating

Wall Street analysts forecast GOCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GOCO is 11.00 USD with a low forecast of 10.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

2 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

10.00

Averages

11.00

High

12.00

Current: 0.000

Low

10.00

Averages

11.00

High

12.00

RBC Capital

Sector Perform

downgrade

$12 -> $5

2025-11-26

Reason

RBC Capital

Price Target

$12 -> $5

2025-11-26

downgrade

Sector Perform

Reason

RBC Capital lowered the firm's price target on GoHealth to $5 from $12 and keeps a Sector Perform rating on the shares. The firm is updating its model following the company's Q3 results, which came in significantly below expectations due to topline weakness as a result of one large carrier suspending its relationship with, the analyst tells investors in a research note.

William Blair

Outperform -> Market Perform

downgrade

2025-11-18

Reason

William Blair

Price Target

2025-11-18

downgrade

Outperform -> Market Perform

Reason

William Blair downgraded GoHealth to Market Perform from Outperform.

William Blair

Outperform -> Market Perform

downgrade

2025-11-18

Reason

William Blair

Price Target

2025-11-18

downgrade

Outperform -> Market Perform

Reason

William Blair downgraded GoHealth to Market Perform from Outperform. Q3 revenue and Medicare submissions were below the firm's expectations as the company pulled back on new enrollment growth, aligning with insurer actions to prioritize profitability and member retention over board member expansion, the analyst tells investors in a research note. The firm added that it believes the decision to limit cash burn is prudent given he challenging market dynamic, though it downgrades the shares given market headwinds that will likely persist through 2026,unccertatinty on GoHealth's ability to generate sustainable positive cash flow, and limited progress in diversifying its business model.

Noble Capital

Patrick McCann

Outperform

downgrade

$20 -> $10

2025-11-14

Reason

Noble Capital

Patrick McCann

Price Target

$20 -> $10

2025-11-14

downgrade

Outperform

Reason

Noble Capital analyst Patrick McCann lowered the firm's price target on GoHealth to $10 from $20 and keeps an Outperform rating on the shares. Q3 results came in below expectations and management expects the current environment to last several quarters as carriers recalibrate benefit structures and cost models, notes the analyst, whose Q4 and 2026 forecasts are now "materially lower than our previous estimates." However, the firm believes the long-term revenue and margin potential remain attractive once the Medicare Advantage market stabilizes, the analyst tells investors.

Noble Capital

Patrick McCann

Outperform

downgrade

$25 -> $20

2025-08-08

Reason

Noble Capital

Patrick McCann

Price Target

$25 -> $20

2025-08-08

downgrade

Outperform

Reason

Noble Capital analyst Patrick McCann lowered the firm's price target on GoHealth to $20 from $25 and keeps an Outperform rating on the shares after the company reported Q2 revenue below the firm's forecast. The firm now expects Q3 revenue to moderate to $100M, down from its prior estimate, and it trimmed both revenue and adjusted EBITDA estimates for 2025, but it continues to anticipate revenue growth and margin expansion in 2026.

Valuation Metrics

The current forward P/E ratio for Gohealth Inc (GOCO.O) is -0.30, compared to its 5-year average forward P/E of -16.59. For a more detailed relative valuation and DCF analysis to assess Gohealth Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-16.59

Current PE

-0.30

Overvalued PE

50.20

Undervalued PE

-83.37

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

10.00

Current EV/EBITDA

-8.65

Overvalued EV/EBITDA

17.84

Undervalued EV/EBITDA

2.16

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.26

Current PS

0.18

Overvalued PS

0.53

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

GOCO News & Events

Events Timeline

No data

News

9.5

2025-11-13NASDAQ.COM

GoHealth (GOCO) Announces Q3 Loss, Falls Short of Revenue Projections

2.0

2025-09-22NASDAQ.COM

Brighthouse Financial (BHF) Rises 27.2%: Is There More Growth Potential for the Stock?

2.0

2025-08-24Benzinga

5 Financial Stocks Face Challenges in Growth, Underperforming Compared to Sector Rivals

People Also Watch

Frequently Asked Questions

What is Gohealth Inc (GOCO) stock price today?

The current price of GOCO is 2.36 USD — it has increased 3.51 % in the last trading day.

What is Gohealth Inc (GOCO)'s business?

GoHealth, Inc. is a medicare-focused digital health company that operates in a health insurance marketplace. The Company primarily offers Medicare plans, including Medicare Advantage, Medicare Supplement and prescription drug plans. Its technology platform leverages modern machine-learning algorithms, powered by insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer’s specific needs. Its Medicare Advantage offerings include Special Needs Plans (SNPs). SNPs are special kinds of Medicare Advantage plans that have benefits covering special health care or financial needs. Its Marketplace technology features decision support tools and integrates with health plan partner enterprise systems, enabling agents to quickly select the right health insurance plan for each consumer based on their specific needs and enroll them in those plans. It offers Encompass Connect and Encompass Engage services to its health plan partners.

What is the price predicton of GOCO Stock?

What is Gohealth Inc (GOCO)'s revenue for the last quarter?

Gohealth Inc revenue for the last quarter amounts to 34.19M USD, decreased -71.10 % YoY.

What is Gohealth Inc (GOCO)'s earnings per share (EPS) for the last quarter?

Gohealth Inc. EPS for the last quarter amounts to -11.80 USD, decreased -2665.22 % YoY.

What changes have occurred in the market's expectations for Gohealth Inc (GOCO)'s fundamentals?

How many employees does Gohealth Inc (GOCO). have?

Gohealth Inc (GOCO) has 2261 emplpoyees as of January 08 2026.

What is Gohealth Inc (GOCO) market cap?

Today GOCO has the market capitalization of 67.77M USD.